Literature DB >> 30488537

Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Meng Han1, Miao Zhao1, Chen Cheng1, Yuan Huang2, Shengna Han3, Wenjuan Li1, Xin Tu1, Xuan Luo1, Xiaoling Yu1, Yinan Liu1, Qiuyun Chen4,5, Xiang Ren1, Qing Kenneth Wang1,4,5, Tie Ke1.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Here, we show the identification and functional characterization of one AF-associated mutation p.Arg399Cys in lamin A/C. Co-immunoprecipitation and GST pull-down assays demonstrate that lamin A/C interacts with NUP155, which is a nucleoporin and causes AF when mutated. Lamin A/C mutation p.Arg399Cys impairs the interaction between lamin A/C and NUP155, and increases extractability of NUP155 from the nuclear envelope (NE). Mutation p.Arg399Cys leads to aggregation of lamin A/C in the nucleus, although it does not impair the integrity of NE upon cellular stress. Mutation p.Arg399Cys inhibits the export of HSP70 mRNA and the nuclear import of HSP70 protein. Electrophysiological studies show that mutation p.Arg399Cys decreases the peak cardiac sodium current by decreasing the cell surface expression level of cardiac sodium channel Nav 1.5, but does not affect IKr potassium current. In conclusion, our results indicate that lamin A/C mutation p.Arg399Cys weakens the interaction between nuclear lamina (lamin A/C) and the nuclear pore complex (NUP155), leading to the development of AF. The findings provide a novel molecular mechanism for the pathogenesis of AF.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  LMNA; NUP155; SCN5A/Nav1.5; atrial fibrillation (AF); mutation

Year:  2018        PMID: 30488537      PMCID: PMC6440547          DOI: 10.1002/humu.23691

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  86 in total

1.  Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.

Authors:  B J Brundel; I C Van Gelder ; R H Henning; R G Tieleman; A E Tuinenburg; M Wietses; J G Grandjean; W H Van Gilst ; H J Crijns
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.

Authors:  Kenshi Hayashi; Tetsuo Konno; Hayato Tada; Satoyuki Tani; Li Liu; Noboru Fujino; Atsushi Nohara; Akihiko Hodatsu; Toyonobu Tsuda; Yoshihiro Tanaka; Masa-aki Kawashiri; Hidekazu Ino; Naomasa Makita; Masakazu Yamagishi
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06-30

3.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

4.  Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death.

Authors:  Xianqin Zhang; Shenghan Chen; Shin Yoo; Susmita Chakrabarti; Teng Zhang; Tie Ke; Carlos Oberti; Sandro L Yong; Fang Fang; Lin Li; Roberto de la Fuente; Lejin Wang; Qiuyun Chen; Qing Kenneth Wang
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

5.  Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.

Authors:  Mikel Allende; Eva Molina; Elisabet Guruceaga; Ibai Tamayo; José Ramón González-Porras; Tomás José Gonzalez-López; Estefanía Toledo; Obdulia Rabal; Ana Ugarte; Vanesa Roldán; José Rivera; Julen Oyarzabal; Ramón Montes; José Hermida
Journal:  Cardiovasc Res       Date:  2016-03-14       Impact factor: 10.787

6.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

7.  The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).

Authors:  Moritz F Sinner; Arne Pfeufer; Mahmut Akyol; Britt-Maria Beckmann; Martin Hinterseer; Annette Wacker; Siegfried Perz; Wiebke Sauter; Thomas Illig; Michael Näbauer; Claus Schmitt; H-Erich Wichmann; Albert Schömig; Gerhard Steinbeck; Thomas Meitinger; Stefan Kääb
Journal:  Eur Heart J       Date:  2008-01-25       Impact factor: 29.983

Review 8.  Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

Authors:  Stanley Nattel; Ange Maguy; Sabrina Le Bouter; Yung-Hsin Yeh
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

9.  Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.

Authors:  Cordula M Wolf; Libin Wang; Ronny Alcalai; Anne Pizard; Patrick G Burgon; Ferhaan Ahmad; Megan Sherwood; Dorothy M Branco; Hiroko Wakimoto; Glenn I Fishman; Vincent See; Colin L Stewart; David A Conner; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

10.  Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.

Authors:  Ingrid A W van Rijsingen; Eline A Nannenberg; Eloisa Arbustini; Perry M Elliott; Jens Mogensen; Johanna F Hermans-van Ast; Anneke J van der Kooi; J Peter van Tintelen; Maarten P van den Berg; Maurizia Grasso; Alessandra Serio; Sharon Jenkins; Camilla Rowland; Pascale Richard; Arthur A M Wilde; Andreas Perrot; Sabine Pankuweit; Aeilko H Zwinderman; Philippe Charron; Imke Christiaans; Yigal M Pinto
Journal:  Eur J Heart Fail       Date:  2012-11-25       Impact factor: 15.534

View more
  13 in total

1.  Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X.

Authors:  Roberta De Zio; Giusy Pietrafesa; Serena Milano; Giuseppe Procino; Manuela Bramerio; Martino Pepe; Cinzia Forleo; Stefano Favale; Maria Svelto; Andrea Gerbino; Monica Carmosino
Journal:  Front Cell Dev Biol       Date:  2022-06-29

Review 2.  Genetic and non-genetic risk factors associated with atrial fibrillation.

Authors:  Lindsay J Young; Steve Antwi-Boasiako; Joel Ferrall; Loren E Wold; Peter J Mohler; Mona El Refaey
Journal:  Life Sci       Date:  2022-04-03       Impact factor: 6.780

3.  Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2.

Authors:  Wenxia Si; Bisheng Zhou; Wen Xie; Hui Li; Ke Li; Sisi Li; Wenbing Deng; Pengcheng Shi; Chao Yuan; Tie Ke; Xiang Ren; Xin Tu; Xiaomei Zeng; Britta Weigelt; Brian P Rubin; Qiuyun Chen; Chengqi Xu; Qing Kenneth Wang
Journal:  Cancer Lett       Date:  2020-10-15       Impact factor: 8.679

4.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

5.  PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.

Authors:  Xiao-Juan Guo; Xing-Biao Qiu; Jun Wang; Yu-Han Guo; Chen-Xi Yang; Li Li; Ri-Feng Gao; Zun-Ping Ke; Ruo-Min Di; Yu-Min Sun; Ying-Jia Xu; Yi-Qing Yang
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

Review 6.  Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target.

Authors:  Stan W van Wijk; Kennedy S Ramos; Bianca J J M Brundel
Journal:  Int J Mol Sci       Date:  2021-01-05       Impact factor: 5.923

7.  Lamin regulates the dietary restriction response via the mTOR pathway in Caenorhabditis elegans.

Authors:  Chayki Charar; Sally Metsuyanim-Cohen; Daniel Z Bar
Journal:  J Cell Sci       Date:  2021-09-06       Impact factor: 5.285

8.  Protein Subdomain Enrichment of NUP155 Variants Identify a Novel Predicted Pathogenic Hotspot.

Authors:  Riley J Leonard; Claudia C Preston; Melanie E Gucwa; Yohannes Afeworki; Arielle S Selya; Randolph S Faustino
Journal:  Front Cardiovasc Med       Date:  2020-02-07

Review 9.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

10.  KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation as well as Ventricular Arrhythmias and Cardiomyopathy.

Authors:  Ning Li; Ying-Jia Xu; Hong-Yu Shi; Chen-Xi Yang; Yu-Han Guo; Ruo-Gu Li; Xing-Biao Qiu; Yi-Qing Yang; Min Zhang
Journal:  Genes (Basel)       Date:  2021-03-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.